CHMP work plan 2026
Submitted by Anonymous (not verified) on 3 February 2026 - 9:51
CHMP work plan 2026
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 9, Status: Authorised
Submitted by Anonymous (not verified) on 3 February 2026 - 9:45
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 3 February 2026 - 9:15
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): GalliaPharm, gallium (68Ga) chloride,germanium (68Ge) chloride, Date of authorisation: 01/08/2024, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 3 February 2026 - 8:00
Human medicines European public assessment report (EPAR): GalliaPharm, gallium (68Ga) chloride,germanium (68Ge) chloride, Date of authorisation: 01/08/2024, Revision: 1, Status: Authorised
Training module EV-M8 - Considerations on the international transfer of personal (health) data in ICSRs -SUSARs originating in the EU
Submitted by Anonymous (not verified) on 2 February 2026 - 16:44
Training module EV-M8 - Considerations on the international transfer of personal (health) data in ICSRs -SUSARs originating in the EU
Training module EV-M8 - Considerations on the international transfer of personal (health) data in ICSRs -SUSARs originating in the EU
Submitted by Anonymous (not verified) on 2 February 2026 - 16:44
Training module EV-M8 - Considerations on the international transfer of personal (health) data in ICSRs -SUSARs originating in the EU
Pre-authorisation guidance under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6)
Submitted by Anonymous (not verified) on 2 February 2026 - 16:24
Pre-authorisation guidance under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6)
Frequently asked questions on the European Shortages Monitoring Platform (ESMP)
Submitted by Anonymous (not verified) on 2 February 2026 - 16:08
Frequently asked questions on the European Shortages Monitoring Platform (ESMP)
COMP work plan 2026
Submitted by Anonymous (not verified) on 2 February 2026 - 15:55
COMP work plan 2026
Qualification of non-mutagenic impurities - Scientific guideline
Submitted by Anonymous (not verified) on 2 February 2026 - 15:50
Qualification of non-mutagenic impurities - Scientific guideline